AngioDynamics Historical Balance Sheet

ANGO Stock

USD 6.32 0.46 7.85%

Trend analysis of AngioDynamics balance sheet accounts such as Total Assets of 533.4 M, Short and Long Term Debt Total of 66.3 M or Other Current Liab of 52.4 M provides information on AngioDynamics' total assets, liabilities, and equity, which is the actual value of AngioDynamics to its prevalent stockholders. By breaking down trends over time using AngioDynamics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining AngioDynamics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AngioDynamics is a good buy for the upcoming year.

AngioDynamics Inventory

42.52 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

About AngioDynamics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. AngioDynamics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AngioDynamics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AngioDynamics currently owns. An asset can also be divided into two categories, current and non-current.

AngioDynamics Balance Sheet Chart

AngioDynamics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how AngioDynamics uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 22nd of May 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab Non Currrent Assets Other Treasury Stock

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of AngioDynamics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AngioDynamics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most accounts from AngioDynamics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 22nd of May 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	33.8M	49.8M	57.3M	66.3M
Total Assets	552.8M	532.6M	612.5M	533.4M

Short Long Term Debt Total Total Assets

AngioDynamics balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.66	0.1	0.36	0.88	0.7	0.52	0.1	-0.15	-0.31	0.44	0.31	0.58	0.16	0.1	0.27	0.7	0.95	-0.34	0.26	0.78	-0.08	0.96	0.5	0.48	0.63
Total Assets	0.66		0.78	0.09	0.67	0.99	0.73	0.28	0.33	0.39	0.26	0.35	0.97	0.1	0.78	0.36	0.76	0.77	0.16	0.84	0.76	0.36	0.73	0.92	0.48	0.72
Short Long Term Debt Total	0.1	0.78		-0.17	0.27	0.68	0.63	0.18	0.66	0.75	0.03	0.13	0.81	0.01	0.99	0.15	0.56	0.24	0.39	0.95	0.43	0.54	0.19	0.89	0.3	0.4
Other Current Liab	0.36	0.09	-0.17		0.5	0.11	0.1	-0.66	-0.38	-0.59	0.8	0.31	-0.05	0.18	-0.13	0.33	0.32	0.37	-0.15	-0.14	0.12	0.01	0.4	0.04	0.08	0.44
Total Current Liabilities	0.88	0.67	0.27	0.5		0.66	0.65	-0.12	0.02	-0.26	0.61	0.26	0.58	0.17	0.28	0.25	0.87	0.9	-0.08	0.34	0.76	0.17	0.91	0.61	0.59	0.66
Total Stockholder Equity	0.7	0.99	0.68	0.11	0.66		0.66	0.35	0.21	0.32	0.25	0.41	0.94	0.15	0.69	0.42	0.72	0.81	0.14	0.75	0.75	0.31	0.77	0.84	0.46	0.77
Property Plant And Equipment Net	0.52	0.73	0.63	0.1	0.65	0.66		-0.2	0.71	0.13	0.44	-0.3	0.82	0.2	0.63	-0.3	0.88	0.63	0.31	0.71	0.82	0.54	0.61	0.8	0.78	0.2
Current Deferred Revenue	0.1	0.28	0.18	-0.66	-0.12	0.35	-0.2		-0.16	0.53	-0.64	0.43	0.25	-0.14	0.17	0.4	-0.19	0.08	-0.07	0.17	-0.02	-0.22	0.05	0.11	-0.08	0.28
Net Debt	-0.15	0.33	0.66	-0.38	0.02	0.21	0.71	-0.16		0.44	-0.01	-0.65	0.52	-0.01	0.64	-0.64	0.43	-0.02	0.48	0.65	0.4	0.59	-0.06	0.56	0.45	-0.34
Retained Earnings	-0.31	0.39	0.75	-0.59	-0.26	0.32	0.13	0.53	0.44		-0.57	0.19	0.43	-0.2	0.74	0.19	-0.02	-0.23	0.33	0.67	-0.08	0.26	-0.28	0.49	-0.1	0.13
Accounts Payable	0.44	0.26	0.03	0.8	0.61	0.25	0.44	-0.64	-0.01	-0.57		0.01	0.19	0.4	0.07	0.05	0.6	0.5	0.02	0.05	0.46	0.35	0.52	0.24	0.39	0.35
Cash	0.31	0.35	0.13	0.31	0.26	0.41	-0.3	0.43	-0.65	0.19	0.01		0.13	0.0	0.16	1.0	0.0	0.28	-0.24	0.1	-0.1	-0.24	0.28	0.17	-0.3	0.85
Non Current Assets Total	0.58	0.97	0.81	-0.05	0.58	0.94	0.82	0.25	0.52	0.43	0.19	0.13		0.08	0.8	0.13	0.76	0.7	0.22	0.89	0.79	0.4	0.65	0.94	0.55	0.53
Other Assets	0.16	0.1	0.01	0.18	0.17	0.15	0.2	-0.14	-0.01	-0.2	0.4	0.0	0.08		0.06	0.03	0.17	0.22	0.15	-0.07	0.15	0.19	0.22	-0.01	0.07	0.12
Long Term Debt	0.1	0.78	0.99	-0.13	0.28	0.69	0.63	0.17	0.64	0.74	0.07	0.16	0.8	0.06		0.18	0.55	0.26	0.44	0.94	0.43	0.57	0.2	0.89	0.27	0.43
Cash And Short Term Investments	0.27	0.36	0.15	0.33	0.25	0.42	-0.3	0.4	-0.64	0.19	0.05	1.0	0.13	0.03	0.18		0.0	0.27	-0.18	0.11	-0.11	-0.2	0.27	0.17	-0.3	0.85
Net Receivables	0.7	0.76	0.56	0.32	0.87	0.72	0.88	-0.19	0.43	-0.02	0.6	0.0	0.76	0.17	0.55	0.0		0.79	0.14	0.6	0.85	0.51	0.77	0.78	0.75	0.5
Common Stock Total Equity	0.95	0.77	0.24	0.37	0.9	0.81	0.63	0.08	-0.02	-0.23	0.5	0.28	0.7	0.22	0.26	0.27	0.79		-0.04	0.36	0.87	0.15	1.0	0.59	0.55	0.68
Short Term Investments	-0.34	0.16	0.39	-0.15	-0.08	0.14	0.31	-0.07	0.48	0.33	0.02	-0.24	0.22	0.15	0.44	-0.18	0.14	-0.04		0.25	0.12	0.71	-0.06	0.18	0.17	-0.07
Non Current Liabilities Total	0.26	0.84	0.95	-0.14	0.34	0.75	0.71	0.17	0.65	0.67	0.05	0.1	0.89	-0.07	0.94	0.11	0.6	0.36	0.25		0.55	0.42	0.31	0.96	0.35	0.41
Inventory	0.78	0.76	0.43	0.12	0.76	0.75	0.82	-0.02	0.4	-0.08	0.46	-0.1	0.79	0.15	0.43	-0.11	0.85	0.87	0.12	0.55		0.43	0.85	0.7	0.63	0.41
Other Current Assets	-0.08	0.36	0.54	0.01	0.17	0.31	0.54	-0.22	0.59	0.26	0.35	-0.24	0.4	0.19	0.57	-0.2	0.51	0.15	0.71	0.42	0.43		0.13	0.41	0.32	0.09
Other Stockholder Equity	0.96	0.73	0.19	0.4	0.91	0.77	0.61	0.05	-0.06	-0.28	0.52	0.28	0.65	0.22	0.2	0.27	0.77	1.0	-0.06	0.31	0.85	0.13		0.55	0.55	0.68
Total Liab	0.5	0.92	0.89	0.04	0.61	0.84	0.8	0.11	0.56	0.49	0.24	0.17	0.94	-0.01	0.89	0.17	0.78	0.59	0.18	0.96	0.7	0.41	0.55		0.48	0.55
Property Plant And Equipment Gross	0.48	0.48	0.3	0.08	0.59	0.46	0.78	-0.08	0.45	-0.1	0.39	-0.3	0.55	0.07	0.27	-0.3	0.75	0.55	0.17	0.35	0.63	0.32	0.55	0.48		0.12
Total Current Assets	0.63	0.72	0.4	0.44	0.66	0.77	0.2	0.28	-0.34	0.13	0.35	0.85	0.53	0.12	0.43	0.85	0.5	0.68	-0.07	0.41	0.41	0.09	0.68	0.55	0.12

Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	38.0M	38.3M	39.0M	39.5M	45.4M	29.4M
Total Assets	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Short Long Term Debt Total	40.8M	20M	33.8M	49.8M	57.3M	66.3M
Other Current Liab	2.1M	38.0M	21.5M	43.4M	49.9M	52.4M
Total Current Liabilities	51.5M	57.6M	74.3M	83.8M	96.4M	48.7M
Total Stockholder Equity	455.9M	439.5M	424.5M	378.3M	435.0M	404.2M
Property Plant And Equipment Net	28.3M	37.1M	45.0M	44.4M	51.0M	35.0M
Net Debt	(13.6M)	(28.2M)	5.0M	5.2M	6.0M	5.7M
Retained Earnings	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Accounts Payable	19.1M	19.6M	28.0M	40.4M	46.5M	48.8M
Cash	54.4M	48.2M	28.8M	44.6M	51.3M	45.7M
Non Current Assets Total	442.6M	420.6M	409.4M	369.1M	424.5M	382.2M
Other Assets	5.2M	3.8M	11.0M	49.2M	56.6M	59.4M
Long Term Debt	40M	20M	25M	49.8M	57.3M	58.7M
Cash And Short Term Investments	54.4M	48.2M	28.8M	44.6M	51.3M	61.7M
Net Receivables	31.3M	35.4M	52.3M	52.8M	60.7M	38.3M
Common Stock Total Equity	374K	377K	380K	382K	439.3K	308.9K
Liabilities And Stockholders Equity	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Non Current Liabilities Total	88.1M	64.4M	53.9M	70.5M	81.1M	80.5M
Inventory	59.9M	48.6M	51.4M	55.3M	63.6M	42.5M
Other Current Assets	2.2M	1.8M	2.2M	4.6M	4.2M	4.5M
Other Stockholder Equity	557.2M	567.8M	581.2M	593.5M	682.5M	424.4M
Total Liab	139.6M	122.0M	128.3M	154.3M	177.5M	129.1M
Property Plant And Equipment Gross	28.3M	37.1M	96.1M	44.4M	51.0M	37.5M
Total Current Assets	152.9M	140.9M	143.3M	163.5M	188.1M	151.2M
Accumulated Other Comprehensive Income	(1.3M)	3.2M	1.4M	(4.7M)	(5.4M)	(5.2M)
Short Term Debt	836K	2.4M	8.8M	14.8M	17.0M	8.5M
Intangible Assets	197.1M	169.0M	152.4M	111.1M	127.8M	113.3M
Common Stock	374K	377K	380K	382K	439.3K	309.7K
Property Plant Equipment	28.3M	37.1M	45.0M	44.4M	51.0M	34.9M
Non Currrent Assets Other	15.6M	13.2M	(5.1M)	54.3M	62.5M	65.6M
Other Liab	39.6M	37.1M	24.2M	17.4M	20.0M	32.6M
Good Will	201.5M	201.3M	201.1M	159.2M	183.1M	283.9M
Net Tangible Assets	57.2M	69.2M	71.1M	378.3M	435.0M	456.8M
Retained Earnings Total Equity	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Long Term Debt Total	40M	20M	25M	49.8M	44.8M	69.2M
Capital Surpluse	561.9M	573.5M	586.9M	599.2M	689.1M	600.4M
Deferred Long Term Liab	24.1M	20.0M	16.0M	12.8M	14.7M	14.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.84)

Revenue Per Share

8.105

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.05)

Return On Equity

(0.62)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Historical Balance Sheet

AngioDynamics Inventory

42.52 Million

About AngioDynamics Balance Sheet Analysis

AngioDynamics Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Non Currrent Assets Other

AngioDynamics balance sheet Correlations

AngioDynamics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AngioDynamics balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for AngioDynamics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding

Current Deferred Revenue	- 0.66	Other Current Liab
Cash	- 0.65	Net Debt
Cash And Short Term Investments	- 0.64	Net Debt
Accounts Payable	- 0.64	Current Deferred Revenue
Retained Earnings	- 0.59	Other Current Liab
Accounts Payable	- 0.57	Retained Earnings